Holen Sie sich die Stockscreener-App
84.91
1.35%
-1.16
Handel nachbörslich:
84.91
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTVA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$86.07
Offen:
$86.8
24-Stunden-Volumen:
2.86M
Relative Volume:
0.77
Marktkapitalisierung:
$56.79B
Einnahmen:
$17.89B
Nettoeinkommen (Verlust:
$1.26B
KGV:
49.86
EPS:
1.7029
Netto-Cashflow:
$2.05B
1W Leistung:
-2.12%
1M Leistung:
+11.52%
6M Leistung:
+21.40%
1J Leistung:
+16.14%
1-Tages-Spanne:
$84.56
$87.42
1-Wochen-Bereich:
$83.23
$87.42
52-Wochen-Spanne:
$60.53
$87.69
Corteva Inc Stock (CTVA) Company Profile
Firmenname
Corteva Inc
Sektor
Branche
Telefon
(833) 267-8382
Adresse
9330 ZIONSVILLE ROAD, INDIANAPOLIS, DE
Compare CTVA vs NTR, CF, MOS, ICL
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTVA
Corteva Inc
|
84.91 | 57.57B | 17.89B | 1.26B | 2.05B | 1.7029 |
NTR
Nutrien Ltd
|
68.64 | 32.45B | 27.83B | 2.42B | 2.21B | 4.9113 |
CF
Cf Industries Holdings Inc
|
119.19 | 18.58B | 7.41B | 2.12B | 1.62B | 11.13 |
MOS
Mosaic Company
|
22.94 | 7.09B | 12.43B | 70.90M | -489.30M | 0.1275 |
ICL
Icl Group Ltd
|
5.01 | 6.36B | 7.41B | 314.00M | 220.88M | 0.202 |
Corteva Inc Stock (CTVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-09 | Herabstufung | UBS | Buy → Neutral |
| 2026-02-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-10-03 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-10-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-10-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-08-13 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-03-31 | Hochstufung | Argus | Hold → Buy |
| 2025-03-13 | Eingeleitet | Goldman | Buy |
| 2024-10-23 | Eingeleitet | Citigroup | Buy |
| 2024-10-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-08-07 | Herabstufung | Argus | Buy → Hold |
| 2024-04-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-03-01 | Eingeleitet | Wolfe Research | Outperform |
| 2024-02-12 | Hochstufung | Loop Capital | Hold → Buy |
| 2024-02-02 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2023-11-27 | Herabstufung | Berenberg | Buy → Hold |
| 2023-11-14 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-10-20 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-09-05 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-25 | Herabstufung | Redburn | Buy → Neutral |
| 2023-06-28 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Hochstufung | Vertical Research | Hold → Buy |
| 2023-04-06 | Eingeleitet | Oppenheimer | Perform |
| 2023-01-19 | Eingeleitet | Wells Fargo | Overweight |
| 2023-01-11 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-11-16 | Herabstufung | UBS | Buy → Neutral |
| 2022-11-15 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-08-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-08-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2022-07-14 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-01 | Eingeleitet | Barclays | Overweight |
| 2022-05-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-14 | Hochstufung | Loop Capital | Hold → Buy |
| 2022-04-14 | Herabstufung | Vertical Research | Buy → Hold |
| 2022-01-31 | Hochstufung | Redburn | Neutral → Buy |
| 2021-10-18 | Herabstufung | Loop Capital | Buy → Hold |
| 2021-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-10-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-09-01 | Eingeleitet | Berenberg | Buy |
| 2021-08-09 | Hochstufung | Monness Crespi & Hardt | Sell → Neutral |
| 2021-05-10 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-04-19 | Hochstufung | Loop Capital | Hold → Buy |
| 2021-02-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-02-05 | Bestätigt | Monness Crespi & Hardt | Sell |
| 2020-12-18 | Herabstufung | Susquehanna | Positive → Neutral |
| 2020-12-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-10 | Hochstufung | Argus | Hold → Buy |
| 2020-10-19 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-10-19 | Herabstufung | Exane BNP Paribas | Outperform → Underperform |
| 2020-08-11 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-08-10 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-07-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-06-26 | Eingeleitet | Cleveland Research | Neutral |
| 2020-06-16 | Hochstufung | Vertical Research | Hold → Buy |
| 2020-06-08 | Herabstufung | Monness Crespi & Hardt | Neutral → Sell |
| 2020-05-11 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-04-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2020-04-17 | Hochstufung | Loop Capital | Sell → Hold |
| 2020-04-01 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-31 | Hochstufung | Susquehanna | Neutral → Positive |
| 2020-03-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-19 | Hochstufung | Edward Jones | Hold → Buy |
| 2020-03-13 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-03-10 | Hochstufung | Monness Crespi & Hardt | Sell → Neutral |
Alle ansehen
Corteva Inc Aktie (CTVA) Neueste Nachrichten
Brazil Leads Global Biologicals Market: Corteva, Micropep, Invaio Strategies | 2026News and Statistics - IndexBox
CTVA Maintained by Mizuho -- Price Target Raised to $97.00 - GuruFocus
Corteva (NYSE:CTVA) Stock Price Expected to Rise, Mizuho Analyst Says - MarketBeat
Mizuho Adjusts Price Target on Corteva to $97 From $96, Maintains Outperform Rating - Moomoo
Mission Produce's Farming Segment: Is a Recovery Underway? - TradingView
Enterprise value to EBITDA forward of Corteva Inc – HAN:2X0 - TradingView
Fifth Third Bancorp Increases Stake in Corteva, Inc. $CTVA - MarketBeat
Arbejdsmarkedets Tillaegspension Sells 38,837 Shares of Corteva, Inc. $CTVA - MarketBeat
Enterprise value to revenue forward of Corteva, Inc. – NYSE:CTVA - TradingView
What to expect from Corteva's next quarterly earnings report - MSN
Enterprise value to revenue forward of Corteva Inc – BMV:CTVA - TradingView
Is Corteva’s (CTVA) Arginex Soy Tie-Up a Subtle Shift in Its Innovation Playbook? - simplywall.st
Corteva Inc. stock outperforms competitors on strong trading day - MarketWatch
CTVA stock holds steady as Corteva keeps its crop portfolio broad - Ad Hoc News
Summit Securities Group LLC Buys 19,107 Shares of Corteva, Inc. $CTVA - MarketBeat
Sumitomo Mitsui Trust Group Inc. Sells 197,471 Shares of Corteva, Inc. $CTVA - MarketBeat
FTC Can't Get Trial Scheduled Against Syngenta & Corteva - Law360
New York sues 3M, DuPont, Corteva and others over so-called forever chemicals - Indianapolis Business Journal
3rd Circ. Questions Standing In DuPont, Corteva Appeals - Law360
Corteva Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Basic Materials: Sector Rises but Underperforms, Leaving Opportunities in Chemicals and Agriculture - Morningstar
Corteva stock trades steadily as crop protection and seed demand support the business - ad-hoc-news.de
What to Expect From Corteva's Next Quarterly Earnings Report - Yahoo Finance
Corteva Inc. stock outperforms competitors despite losses on the day - MarketWatch
Corteva focuses on crop protection and seed innovation as a global agriculture pure play - ad-hoc-news.de
Is AVO's Sustainable Growth Strategy Built for the Long Run? - TradingView
What Does Corteva's (NYSE:CTVA) Arevo Deal Mean for S&P 500? - Kalkine Media
Responsive Playbooks and the CTVA Inflection - Stock Traders Daily
Is Corteva (CTVA) Stock Rich Or Reasonable As Breakups Near? - Yahoo Finance
Price to sales forward of Corteva, Inc. – NYSE:CTVA - TradingView
Does Integrating Arginex Soy Into Seed Treatments Deepen Corteva’s Biologicals Strategy (CTVA)? - simplywall.st
How Adding Arginex Soy to Seed Treatments at Corteva (CTVA) Has Changed Its Investment Story - Yahoo Finance
Corteva and Arevo Partner on Soy Crop Nutrition - GlobeNewswire
Bronte Capital Management Pty Ltd. Has $42.09 Million Stock Position in Corteva, Inc. $CTVA - MarketBeat
CTVACorteva Inc Volatility & Greeks - Finviz
Mizuho Securities Maintains Corteva(CTVA.US) With Buy Rating, Raises Target Price to $96 - Moomoo
Rimisoxafen herbicide technology announced by two companies - High Plains Journal
Corteva stock hits all-time high at 85.64 USD - Investing.com UK
Corteva stock hits all-time high at 85.64 USD By Investing.com - Investing.com Australia
Pesticide Giant Syngenta Appoints New CEO - marketscreener.com
Farm Hands on the Potomac: Olivia Bridges joins Agri-Pulse team, Corteva announces boards of directors, Donna Garren appointed to FDA role - Agri-Pulse
Corteva names boards of directors for new crop protection and seed companies - Indianapolis Business Journal
Corteva | 3: Initial statement of beneficial ownership of securities- KISSAM LUTHER C IV - Moomoo
Corteva Currently Up 10 Consecutive Days, on Pace for Longest Winning Streak Since October 2022 -- Data Talk - Moomoo
Disruption in the Agricultural Sector: Why Corteva and Deere & Company Are Keeping an Eye on MustGrow Biologics - news.financial
Corteva names board for crop protection spinoff - Investing.com UK
Corteva (CTVA) Announces Board Resignations Ahead of Seed Busine - GuruFocus
Corteva Details Board for Future Crop Protection Spinoff - TipRanks
Corteva names board for crop protection spinoff By Investing.com - Investing.com Australia
Karen Grimes, Marcos Lutz, Charles Magro and Kerry Preete to Resign from Corteva Board Ahead of Vylor Spin-Off - TradingView
Corteva (CTVA) details Corteva and Vylor boards as 4Q 2026 spin-off nears - Stock Titan
Finanzdaten der Corteva Inc-Aktie (CTVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.54%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):